BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2942395)

  • 1. The role of opiate peptides in the mechanisms leading to the disturbances of pulsatile secretion of LH in hyperprolactinaemic women.
    Baranowska B; Dorobek W; Misiorowski W; Jeske W
    Endokrynol Pol; 1986; 37(1):1-10. PubMed ID: 2942395
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.
    Reid RL; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1107-10. PubMed ID: 6313728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Endorphin modulates the inhibitory action of corticotropin-releasing factor on luteinizing hormone secretion.
    Petraglia F; Vale W; Rivier C
    NIDA Res Monogr; 1986; 75():331-4. PubMed ID: 2893271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
    Sarkar DK; Yen SS
    Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.
    Veldhuis JD; Rogol AD; Samojlik E; Ertel NH
    J Clin Invest; 1984 Jul; 74(1):47-55. PubMed ID: 6429197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
    Ebling FJ; Schwartz ML; Foster DL
    Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of luteinizing hormone release by morphine and endogenous opiates in cultured pituitary cells.
    Blank MS; Fabbri A; Catt KJ; Dufau ML
    Endocrinology; 1986 May; 118(5):2097-101. PubMed ID: 3009150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.
    Petraglia F; Vale W; Rivier C
    Endocrinology; 1986 Dec; 119(6):2445-50. PubMed ID: 2877862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opiates modulate pulsatile luteinizing hormone release in humans.
    Ropert JF; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1981 Mar; 52(3):583-5. PubMed ID: 6780598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic opioid mechanisms in experimental uremic hypogonadism.
    Dong QH; Handelsman DJ
    Endocrinology; 1990 Mar; 126(3):1498-503. PubMed ID: 2137774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Kato K; Shima K
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
    Lafuente A; Marcó J; Esquifino AI
    Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin-A suppresses the pulsatile secretion of luteinizing hormone via beta-endorphin.
    Irahara M; Tamura T; Matuzaki T; Saito S; Yasui T; Yamano S; Kamada M; Aono T
    Biochem Biophys Res Commun; 2001 Feb; 281(1):232-6. PubMed ID: 11178985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic Ghrelin suppresses pulsatile secretion of luteinizing hormone via beta-endorphin in ovariectomized rats.
    Ogata R; Matsuzaki T; Iwasa T; Kiyokawa M; Tanaka N; Kuwahara A; Yasui T; Irahara M
    Neuroendocrinology; 2009; 90(4):364-70. PubMed ID: 19907132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA; Lam NY; Ferin M
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.